clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association

[1] Clinical Features of COVID-19-Related Liver Damage.

[2] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus

[3] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus

[4] Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies

[5] Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design

[6] De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery

[7] predictors of the efficiency of short-term interferon-containing therapy using direct-acting antiviral drugs in patients with chronic hepatitis c virus genotype 1

[8] when should antiviral drugs be used for the patient with an ebola virus infection?

[9] crystal structures, thermal analysis, and dissolution behavior of new solid forms of the antiviral drug arbidol with dicarboxylic acids

[10] atividade de três drogas antivirais sobre os herpesvírus bovino tipos 1, 2 e 5 em cultivo celular activity of three antiviral drugs against bovine herpesviruses 1, 2 and 5 in cell culture

[11] antiviral drug profile of human influenza a & b viruses circulating in india: 2004-2011

[12] inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase

[13] viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza a(h7n9) virus in zhejiang, china, 2013

[14] The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort